影音:《線上癲癇教室》~劉祐岑醫師線上演講

臺北榮總癲癇及相關疾病基因研究檢測服務

英文履歷 (CV)

得獎紀錄:

2023 (112年)臺北榮民總醫院醫療創新中心『青創提案大賽新媒體應用組』優選獎

2023 (112年)台灣癲癇醫學會研究論文獎第二名。

2021亞太神經學大會(Asian Oceanian Congress of Neurology)最佳論文及口頭發表。

2021 (110年)第17屆榮總台灣聯合大學合作研究計畫優良論文第二名。

2020台灣神經學學會年會論文口頭發表最佳論文及口頭發表。

2019 (108年)學年度台北榮民總醫院實習醫學生票選最佳主治醫師。

2019 (108年)第15屆榮總台灣聯合大學合作研究計畫『優良壁報論文』第一名

2017第四屆台灣巴金森暨動作障礙疾病研討會(Taiwan International Congress of Parkinson Disease and Movement Disorders)優秀論文。

2017 (106年)臺北榮民總醫院PGY票選優良教學醫師

2017 (106年)台灣動作障礙學會年會優秀論文銅牌獎。

2017 (106年)台灣癲癇醫學會研究論文獎第一名。

國立陽明交通大學醫學系109學年上下學期優良教師。

國立陽明大學醫學系105~108學年上下學期優良教師。

國立陽明大學醫學系105~107學年PBL引導老師優良教師

論文著作：*Corresponding author, # equal contribution

1. Improvement in Executive Function and Dual-task Cost in People With Parkinson Disease: A Randomized Controlled Trial. Zhou JH, Wang RY, Liu YT, Cheng SJ, Liu HH, Yang YR*. J Neurol Phys Ther, Accepted on 2024 May 12.(SCI)
2. Magnetic resonance radiomics-derived sphericity correlates with seizure in brain arteriovenous malformations. Lin JY, Lu CF, Hu YS, Yang HC, Liu YT, Loo JK, Lee KL, Liao CY, Chang FC, Liou KD, Lin CJ*. Eur Radiol. 2024 Jan;34(1):588-599.(SCI)
3. Monogenic causes in familial stroke across intracerebral hemorrhage and ischemic stroke subtypes identified by whole exome sequencing. Chang LH, Chi NF, Chen CY, Lin YS, Hsu SL, Ysai JY, Hunag HC, Lin CJ, Chung CP, Tung CY, Jeng CJ, Lee YC, Liu YT*^#, Lee IH*^#. Cell Mol Neurobiol. 2023 Aug;43(6):2769-2783.(SCI)
4. Plasma Matrix Metalloproeteinase‑9 Is Associated with Seizure and Angioarchitecture Changes in Brain Arteriovenous Malformations. Liu YT, Lee CC, Chang FC, Liou KD, Lin CC*. Mol Neurobiol. 2022 Oct;59(10):5925-5934.(SCI)
5. Clinical characteristics and long-term outcome of cerebral cavernous malformations-related epilepsy. Shih YC, Chou CC, Peng SJ, Yu HY, Hsu SPC, Lin CF, Lee CC, Yang HC, Chen YC, Kwan SY, Chen C, Wang SJ, Lin CJ, Lirng JF, Shih YH, Yen DJ, Liu YT*. Epilepsia. 2022 Aug;63(8):2056- 2067.(SCI)
6. Novel Lissencephaly-Associated DCX Variants in the C-terminal DCX Domain Affect Microtubule Binding and Dynamics. Lin JR^#, Cheng JF^#, Liu YT, Hsu TR, Lin KM, Chen C, Lin CL, Tsai MH, Tsai JW*. Epilepsia. 2022 May;63(5):1253-1265.(SCI)
7. The clinical and imaging features of FLNA positive and negative periventricular nodular heterotopia. Lu YT, Hsu CY, Liu YT, Chang CK, Chuang YC, Lin CJ, Chang KP, Ho CJ, Ng CC, Lim KS, Tsai MH*. Biomed J. 2022 Jun;45(3):542-548.(SCI)
8. Acute withdrawal of new-generation antiepileptic drugs in epilepsy monitoring units: Safety and efficacy. Chou CC, Lin PT, Yen DJ, Yu HY, Kwan SY, Chen C, Liu YT, Shih YC, Lin SY*. Epilepsy Behav. 2021 Apr;117:107846.(SCI)
9. Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late onset amyloidosis and neurodegeneration. R B Ibrahim, SY Yeh, KP Lin, F Ricardo, TY Yu, CC Chan, JW Tsai*^#, YT Liu*^#. Cell Mol Life Sci. 2020 Apr;77(7):1421-1434. (SCI)
10. Gamma Knife radiosurgery for cerebral cavernous malformation. Lee CC, Wang WH, Yang HC, Lin CJ, Wu HM, Lin YY, Hu YS, Chen CJ, Chen YW, Chou CC, Liu YT, Chung WY, Shiau CY, Guo WY, Hung-Chi Pan D, Hsu SPC. Sci Rep. 2019 Dec 24;9(1):19743. (SCI)
11. Biophysical characterization and pharmacological modulation of Transthyretin Ala97Ser mutant. YT Liu, YJ Yen, F Ricardo, Y Chang, PH Wu, SJ Huang, KP Lin*, TY Yu*. Ann Clin Transl Neurol. 2019 Oct;6(10):1961-1970.(SCI)
12. Novel SCA19/22-associated KCND3 mutations disrupt human KV4.3 protein biosynthesis and channel gating. Hsiao CT, Fu SJ, Liu YT, Liao YC, Lu YH, Huang JJ, Chien YC, Zhong CY, Tsai PC, Tang CY, Lee YC, Soong BW*, Jeng CJ*. Hum Mutat. 2019 Nov;40(11):2088-2107.
13. PDXK mutations cause polyneuropathy responsive to PLP supplementation. Chelban V, Wilson MP, Warman Chardon J, Vandrovcova J, Zanetti MN, Zamba-Papanicolaou E, Efthymiou S, Pope S, Conte MR, Abis G, Liu YT, Tribollet E, Haridy NA, Botía JA, Ryten M, Nicolaou P, Minaidou A, Christodoulou K, Kernohan KD, Eaton A, Osmond M, Ito Y, Bourque P, Jepson JEC, Bello O, Bremner F, Cordivari C, Reilly MM, Foiani M, Heslegrave A, Zetterberg H, Heales SJR, Wood NW, Rothman JE, Boycott KM, Mills PB, Clayton PT, Houlden H*; Care4Rare Canada Consortium; SYNaPS Study Group. Ann Neurol. 2019 Aug;86(2):225-240.
14. Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan. Chao HC, Liao YC, Liu YT, Guo YC, Chang FP, Lee YC*, Lin KP*. Ann Clin Transl Neurol. 2019 Apr 9;6(5):913-922.
15. PRRT2 Missense Mutations Cluster near C-terminus and Frequently Lead to Protein Mislocalization. Tsai MH, Nian FS, Hsu MH, Liu WS, Liu YT, Liu C, Lin PH, Hwang DY, Chuang YC, Tsai JW*. Epilepsia. 2019 May;60(5):807-817. (SCI)
16. Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis. Ibrahim RB, Liu YT, Yeh SY, Tsai JW. Front Physiol. 2019 Apr 2;10:338. doi: 10.3389/fphys.2019.00338. eCollection 2019. Review. (SCI)
17. Aberrant sensory gating of the primary somatosensory cortex contributes to the motor circuit dysfunction in paroxysmal kinesigenic dyskinesia. Liu YT, Chen YC, Kwan SY, Chou CC, Yu HY, Yen DJ, Liao KK, Chen WT, Lin YY, Chen RS, Jih KY, Lu SF, Wu YT, Wang PS, Hsiao FJ*. Front Neurol. 2018 Oct 15;9:831. (SCI)
18. Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression. Liu YT, Lee YC, Yang CC, Chen ML, Lin KP. J Neurol Sci. 2008 Apr 15;267(1-2):91-9. (SCI)